Oseltamivir Export Market Intelligence: India's 118 Suppliers Shipping to 79 Countries — TransData Nexus 2026

Q: Who are the top oseltamivir exporters from India?

The top oseltamivir exporters from India are: 1. NATCO PHARMA LIMITED — $22.1M (18.0% market share); 2. HETERO LABS LIMITED — $21.9M (17.8% market share); 3. MSN LABORATORIES PRIVATE LIMITED — $20.7M (16.9% market share); 4. STRIDES PHARMA SCIENCE LIMITED — $11.9M (9.7% market share); 5. LUPIN LIMITED — $9.0M (7.3% market share). Together they account for 69.7% of India's total oseltamivir export value.

Q: What is the total export value of oseltamivir from India?

The total export value of oseltamivir from India is $122.6M USD, recorded across 2,149 shipment transactions from 118 active exporters to 79 destination countries. The average shipment value is $57.1K.

Q: Which countries import oseltamivir from India?

India exports oseltamivir to 79 countries worldwide. The top importing countries are: UNITED STATES (59.0% share, $72.4M), CHINA (10.7% share, $13.1M), CANADA (10.6% share, $13.0M), UKRAINE (4.1% share, $5.1M), PHILIPPINES (1.8% share, $2.2M). These five markets account for 86.3% of total export value.

Q: What is the HS code for oseltamivir exports from India?

The primary HS code for oseltamivir exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of oseltamivir exports from India?

The average unit price for oseltamivir exports from India is $3.50 USD per unit, with prices ranging from $0.01 to $248.25 depending on formulation, packaging, and order volume. The total market is valued at $122.6M across 2,149 shipments.

Q: Which ports handle oseltamivir exports from India?

The primary ports for oseltamivir exports from India are SAHAR AIR CARGO ACC (INBOM4) (16.2% of shipments), CHENNAI AIR CARGO ACC (INMAA4) (9.4% of shipments), HYDERABAD ACC (INHYD4) (8.5% of shipments), SAHAR AIR (7.0% of shipments), HYDERABAD ICD (INSNF6) (6.0% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of oseltamivir?

India is one of the world's leading exporters of oseltamivir due to its large base of 118 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports oseltamivir to 79 countries, demonstrating 41% global market coverage.

Q: What certifications do Indian oseltamivir exporters need?

Indian oseltamivir exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import oseltamivir from India?

There are 314 registered buyers importing oseltamivir from India, spread across 79 countries. The repeat buyer rate is 55.1%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top oseltamivir supplier from India?

NATCO PHARMA LIMITED is the leading oseltamivir exporter from India with a market share of 18.0% and total export value of $22.1M across 176 shipments. The top 5 suppliers together control 69.7% of total export value.

Suresh Sormare

Oseltamivir

India Pharmaceutical Trade Intelligence

$122.6M118 Suppliers79 CountriesHS 30049099

ExportsIndia → UNITED STATES59.0%India → CHINA10.7%

ImportsBULGARIA → India$39.0K UNITED STATES → India$21.6K

#1 Supplier: NATCO PHARMA #1 Buyer: EVERSANA LIFE

Oseltamivir Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Oseltamivir to the World

Between 2022 and 2026, India exported $122.6M worth of oseltamivir across 2,149 verified shipments to 79 countries — covering 41% of world markets in the Antivirals segment. The largest destination is UNITED STATES (59.0%). NATCO PHARMA LIMITED leads with a 18.0% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·HS 30049099

Oseltamivir export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Oseltamivir export data snapshot — $122.6M · 118 exporters · 79 countriesTransData Nexus · Indian Customs Data

Top Oseltamivir Exporters from India

118 active exporters · Ranked by export value

View all 118 →

Top Oseltamivir Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	NATCO PHARMA LIMITED	$22.1M	176	7	18.0%
2	HETERO LABS LIMITED

Top Countries Importing Oseltamivir from India

79 destination markets · Ranked by import value

All 79 countries →

Top Countries Importing Oseltamivir from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	UNITED STATES	$72.4M	59.0%
2	CHINA	$13.1M	10.7%
3	CANADA	$13.0M	10.6%
4	UKRAINE	$5.1M	4.1%
5	PHILIPPINES	$2.2M	1.8%
6	SOUTH AFRICA	$2.2M	1.8%
7	BRAZIL	$2.0M	1.7%
8	KAZAKHSTAN	$1.9M	1.6%
9	HONG KONG	$1.8M	1.4%
10	NEW ZEALAND	$1.5M	1.2%

UNITED STATES is India's largest oseltamivir export destination, absorbing 59.0% of total exports worth $72.4M. The top 5 importing countries — UNITED STATES, CHINA, CANADA, UKRAINE, PHILIPPINES — together account for 86.3% of India's total oseltamivir export value. The remaining 74 destination countries collectively receive the other 13.7%, indicating a broadly diversified export footprint across multiple regions.

Who Supplies Oseltamivir to India?

5 origin countries · Total import value: $64.7K

India imports oseltamivir from 5 countries with a combined import value of $64.7K. The largest supplier is BULGARIA ($39.0K, 15 shipments), followed by UNITED STATES and NETHERLANDS. All values are from Indian Customs (DGFT) import records.

Countries Supplying Oseltamivir to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	BULGARIA	$39.0K	15	60.3%
2	UNITED STATES	$21.6K	26	33.4%
3	NETHERLANDS	$4.0K	2	6.2%
4	SINGAPORE	$82	1	0.1%
5	TURKEY	$22	2	0.0%

BULGARIA is the largest supplier of oseltamivir to India, accounting for 60.3% of total import value. The top 5 origin countries — BULGARIA, UNITED STATES, NETHERLANDS, SINGAPORE, TURKEY — together supply 100.0% of India's oseltamivir imports. Click any country to see detailed supplier and buyer data for that import corridor.

Regulatory Landscape — Oseltamivir

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

Oseltamivir, marketed under the brand name Tamiflu, received its initial FDA approval in October 1999 for the treatment of influenza. The first generic version was approved in August 2016. As of March 2026, multiple Abbreviated New Drug Applications (ANDAs) for oseltamivir have been approved, reflecting a competitive generic market. The United States remains the primary destination for Indian oseltamivir exports, accounting for 59.0% of total exports. This robust demand underscores the importance of compliance with FDA regulations, including adherence to Current Good Manufacturing Practices (cGMP) and timely reporting of adverse events.

2EU & UK Regulatory Framework

The European Medicines Agency (EMA) granted marketing authorization for oseltamivir in June 2002. (ema.europa.eu) In the United Kingdom, the Medicines and Healthcare products Regulatory Agency (MHRA) oversees the approval and monitoring of oseltamivir. Manufacturers exporting to these regions must comply with the EU's Good Manufacturing Practice (GMP) guidelines, ensuring product quality and safety. Regular inspections and adherence to pharmacovigilance requirements are essential for maintaining market access.

3WHO Essential Medicines & Global Standards

Oseltamivir is included in the 23rd edition of the WHO Model List of Essential Medicines, published in July 2023. (who.int) This inclusion highlights its significance in global health. The WHO Prequalification Programme has prequalified oseltamivir phosphate, indicating compliance with international quality standards. (extranet.who.int) Manufacturers must ensure that their products meet the specifications outlined in major pharmacopoeias, such as the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP).

4India Regulatory Classification

In India, oseltamivir is classified under Schedule H1 of the Drugs and Cosmetics Rules, requiring a prescription for dispensing. The National Pharmaceutical Pricing Authority (NPPA) has not imposed a ceiling price on oseltamivir, allowing market-driven pricing. Exporters must obtain a No Objection Certificate (NOC) from the Directorate General of Foreign Trade (DGFT) for oseltamivir shipments, ensuring compliance with export regulations.

5Patent & Exclusivity Status

The primary patents for oseltamivir, originally held by Gilead Sciences and licensed to Roche, expired in 2016. (wipo.int) This expiration has led to increased generic competition, with numerous manufacturers entering the market. Indian exporters have capitalized on this opportunity, with 118 active exporters and a total export value of $122.6 million USD.

6Recent Industry Developments

In June 2025, the WHO updated its Model List of Essential Medicines, reaffirming the inclusion of oseltamivir, underscoring its continued importance in influenza treatment. (who.int) In September 2025, the EMA issued updated guidelines on the use of antiviral agents, including oseltamivir, in response to emerging influenza strains, emphasizing the need for ongoing pharmacovigilance. (ema.europa.eu) In November 2025, the NPPA conducted a review of antiviral drug pricing, including oseltamivir, to ensure affordability and accessibility during the influenza season. In January 2026, the CDSCO issued a notification requiring enhanced reporting of adverse drug reactions for oseltamivir, aiming to strengthen patient safety measures. In March 2026, the DGFT streamlined the export NOC process for pharmaceuticals, including oseltamivir, to facilitate timely international shipments.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Oseltamivir

Retail & reference prices across 9 markets vs. India FOB export price of $3.50/unit

Global Price Benchmark for Oseltamivir across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$10.00	USD	According to the FDA's Orange Book, oseltamivir is approved for use in the United States.
United Kingdom	$6.50	GBP	As per the NHS Drug Tariff, oseltamivir is listed for use in the UK.
Germany	$7.00	EUR	The European Medicines Agency (EMA) has approved oseltamivir for use in Germany.
Australia	$5.50	AUD

Supply Chain Risk Assessment — Oseltamivir

API sourcing, concentration risk, storage requirements, and current alerts

HIGH RISK

1API Sourcing & Raw Material Dependency

Oseltamivir, an antiviral medication, relies on specific Active Pharmaceutical Ingredients (APIs) and Key Starting Materials (KSMs) for its production. A significant portion of these KSMs are sourced from China, which dominates 70–80% of the global KSM supply and 60–70% of the global intermediate supply. This heavy reliance on a single country for critical raw materials introduces substantial supply chain vulnerabilities.

Recent disruptions have highlighted these risks. In February 2026, military escalations in the Middle East led to the closure of the Strait of Hormuz, a vital shipping route. This event caused immediate disruptions in the transportation of petrochemicals and other essential materials, underscoring the fragility of supply chains dependent on specific geographic regions. Such geopolitical events can have cascading effects on the availability of KSMs necessary for Oseltamivir production.

2Supplier Concentration & Single-Source Risk

Our proprietary trade data from 2022 to 2026 indicates that the top five Indian exporters of Oseltamivir account for 69.7% of total exports, with NATCO PHARMA LIMITED alone contributing 18.0%. This high concentration among a few suppliers poses a significant risk; any operational or regulatory issues affecting these key players could disrupt the global supply of Oseltamivir.

To mitigate such risks, the Indian government has implemented the Production Linked Incentive (PLI) scheme aimed at reducing dependency on imports for critical pharmaceutical ingredients. In October 2024, two greenfield plants were inaugurated under this scheme to manufacture essential molecules like Penicillin G and 6-APA, which are crucial for antibiotic production. While this initiative is a positive step, its impact on diversifying Oseltamivir's supply chain remains to be seen.

Access Complete Oseltamivir Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 2,149 transactions across 79 markets.

Request Demo View Pricing

Frequently Asked Questions — Oseltamivir Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top oseltamivir exporters from India?

The leading oseltamivir exporters from India are NATCO PHARMA LIMITED, HETERO LABS LIMITED, MSN LABORATORIES PRIVATE LIMITED, and 12 others. NATCO PHARMA LIMITED leads with 18.0% market share ($22.1M). The top 5 suppliers together control 69.7% of total export value.

What is the total export value of oseltamivir from India?

The total export value of oseltamivir from India is $122.6M, recorded across 2,149 shipments from 118 active exporters to 79 countries. The average shipment value is $57.1K.

Which countries import oseltamivir from India?

India exports oseltamivir to 79 countries. The top importing countries are UNITED STATES (59.0%), CHINA (10.7%), CANADA (10.6%), UKRAINE (4.1%), PHILIPPINES (1.8%), which together account for 86.3% of total export value.

What is the HS code for oseltamivir exports from India?

The primary HS code for oseltamivir exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Oseltamivir

Oseltamivir

Top Oseltamivir Exporters from India

Top Countries Importing Oseltamivir from India

Who Supplies Oseltamivir to India?

Quick Facts

Related Antivirals

Related Analysis

Need Details?

Regulatory Landscape — Oseltamivir

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Oseltamivir

Supply Chain Risk Assessment — Oseltamivir

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Oseltamivir Trade Intelligence

Frequently Asked Questions — Oseltamivir Exports from India

Who are the top oseltamivir exporters from India?

What is the total export value of oseltamivir from India?

Which countries import oseltamivir from India?

What is the HS code for oseltamivir exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of oseltamivir exports from India?

Which ports handle oseltamivir exports from India?

Why is India a leading exporter of oseltamivir?

What certifications do Indian oseltamivir exporters need?

How many buyers import oseltamivir from India?

What is the market share of the top oseltamivir exporter from India?

Analysis Methodology